In Fig. 6A–D, it was observed that the use of TNFRSF21 shRNA resulted in a higher accumulation of MDA and ROS in DDP-resistant lung cancer cells compared to the control group. This evidence concerns the gene TNFRSF21 and lung carcinoma.